The concept of response to therapy in differentiated thyroid cancer (DTC) was introduced as
a dynamic risk stratification used to assess the status of the disease at the time of the�…

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate�…

Context Controversy surrounds the extent and intensity of the management of American
Thyroid Association (ATA) intermediate-and low-risk patients with differentiated thyroid�…

Abstract Context The American Thyroid Association (ATA) risk stratification system predicts
risk of recurrence of differentiated thyroid cancer (DTC). Although the majority of patients�…

Objective: The treatment of patients with differentiated thyroid cancer (DTC) was modified in
the last decade towards a more individualized approach according to the risk of recurrence�…

Introduction After initial treatment, differentiated thyroid cancer (DTC) patients are stratified
as low and high risk based on clinical/pathological features. Recently, a risk stratification�…

Background Up to 30% of differentiated thyroid cancer (DTC) will develop advanced-stage
disease (aDTC) with reduced overall survival (OS). Objective The aim of this study is to�…

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total�…

Aim The aim of this study was to validate the effectiveness of delayed risk stratification (DRS)
in predicting structural progression and compare the predictive value of American Thyroid�…

Simple Summary In patients with differentiated thyroid cancer (DTC), the American Thyroid
Association dynamic risk stratification system has been proposed to identify patients at�…